B-Cell Chronic Lymphocytic Leukemia
Showing 1 - 25 of 65
Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- Anti-CD19 and anti-CD20 bicistronic CAR T- cells
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 10, 2023
Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States
Completed
- Non-Hodgkin's Lymphoma, Relapsed
- +8 more
- PBCAR20A
- +2 more
-
Duarte, California
- +4 more
Jan 4, 2023
B-cell Non Hodgkin Lymphoma, B-cell Chronic Lymphocytic Leukemia Trial in Milwaukee (Dose Level -1: 0.75x10^6 cells/kg
Recruiting
- B-cell Non Hodgkin Lymphoma
- B-cell Chronic Lymphocytic Leukemia
- Dose Level -1: 0.75x10^6 cells/kg CAR20.19.22 cells
- +3 more
-
Milwaukee, WisconsinMedical College of Wisconsin and Froedtert Hospital
Jul 1, 2022
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16
Recruiting
- B-cell Chronic Lymphocytic Leukemia
- +3 more
- Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
- +5 more
-
Duarte, California
- +12 more
Jun 16, 2022
B-cell Chronic Lymphocytic Leukemia Trial in Peking (Alemtuzumab)
Suspended
- B-cell Chronic Lymphocytic Leukemia
- Alemtuzumab
-
Peking, Beijing, ChinaPeking University Cancer Hospital
Jun 15, 2022
Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19
Terminated
- Lymphoma, B-Cell
- +3 more
- Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2022
B-cell Chronic Lymphocytic Leukemia Trial in Worldwide (Lenalidomide, Placebo)
Completed
- B-cell Chronic Lymphocytic Leukemia
- Lenalidomide
- Placebo
-
Phoenix, Arizona
- +240 more
Nov 24, 2021
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +71 more
- lenalidomide
- +8 more
-
Chicago, Illinois
- +5 more
Oct 8, 2021
Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee
Enrolling by invitation
- Monoclonal Gammopathy of Undetermined Significance
- +6 more
-
Milwaukee, WisconsinAurora Health Care
Jul 20, 2021
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 14, 2021
B-Cell Chronic Lymphocytic Leukemia Trial in Worldwide (Chlorambucil, Obinutuzumab, Placebo)
Terminated
- B-Cell Chronic Lymphocytic Leukemia
- Chlorambucil
- +4 more
-
Haifa, Israel
- +13 more
Apr 6, 2021
B-Cell Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis) Trial in Huixquilucan
Completed
- B-Cell Chronic Lymphocytic Leukemia
- B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)
- Ibrutinib
- +2 more
-
Huixquilucan, Estado De México, MexicoGrupo Cooperativo de Hemopatías Malignas
Feb 1, 2021
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- Akt inhibitor MK2206
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2020
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +4 more
- alemtuzumab
- +9 more
-
Rochester, MinnesotaMayo Clinic
Jun 11, 2020
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020
B-Cell Chronic Lymphocytic Leukemia Trial in Vilnius (Rituximab, Glucocorticoid)
Completed
- B-Cell Chronic Lymphocytic Leukemia
-
Vilnius, LithuaniaVilnius University Hospital Santaros Klinikos
Dec 17, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +44 more
- fludarabine phosphate
- +9 more
-
Duarte, California
- +6 more
Sep 6, 2019
B-Cell Chronic Lymphocytic Leukemia Trial in Worldwide (Lenalidomide, Chlorambucil)
Completed
- B-Cell Chronic Lymphocytic Leukemia
-
Escondido, California
- +164 more
Jun 14, 2019
Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia Trial
Completed
- Hematopoietic/Lymphoid Cancer
- +22 more
- CART-19
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Jun 21, 2019
B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (Samalizumab)
Terminated
- B-cell Chronic Lymphocytic Leukemia
- Multiple Myeloma
-
Tucson, Arizona
- +3 more
Feb 12, 2019
B-cell Lymphoma Recurrent, B-cell Chronic Lymphocytic Leukemia Trial in Beijing, Nanjing, Tianjin (YY-20394)
Unknown status
- B-cell Lymphoma Recurrent
- B-cell Chronic Lymphocytic Leukemia
-
Beijing, Beijing, China
- +2 more
Dec 6, 2018
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose
Terminated
- Lymphoma, Large B-Cell, Diffuse
- +20 more
- ASN002 Dose Escalation
- ASN002 RD
-
Tempe, Arizona
- +13 more
Aug 13, 2018
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +117 more
- vorinostat
- +5 more
-
Ann Arbor, MichiganUniversity of Michigan University Hospital
Jun 28, 2018
B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma Trial in
Terminated
- B-cell Adult Acute Lymphoblastic Leukemia
- +26 more
- 6,8-bis(benzylthio)octanoic acid
- +3 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jun 29, 2018